Stream 6 Session #6: Free communications- Advances in type 1 diabetes
Tracks
Meeting Room 103
| Wednesday, August 19, 2026 |
| 4:00 PM - 6:00 PM |
| Meeting Room 103 (Level 1) |
Speaker
Mr Chun Kwan O
PhD Student
The Chinese University of Hong Kong
Delayed recognition of autoimmunity with incongruent management: A focused review of 46 latent autoimmune diabetes cases in a RCT cohort of young-onset ‘non-type 1’ diabetes
4:00 PM - 4:15 PMBiography
Chun-Kwan O is a PhD student in Medical Sciences in the Chinese University of Hong Kong. He is working on precision and structured care of individuals with young-onset diabetes.
Takahiro Tosaki
Physician
TDE Healthcare Corporation Tosaki Clinic For Diabetes And Endocrinology
Daily glycemic variability after switching to once-weekly insulin icodec: A real-world study using CGM data
4:15 PM - 4:30 PMBiography
Takahiro Tosaki, M.D., Ph.D., is the Director of Tosaki Clinic for Diabetes and Endocrinology. He serves as Secretary General of the Aichi Council for CDE and a member of the Japan Diabetes Society. He is dedicated to advancing diabetes care through clinical excellence and medical staff education.
Assoc Prof Harshal Deshmukh
Staff Specialist
Gold Coast University Hospital
Insulin dose normalised time in range (dTIR): A novel metric quantifying glycaemic benefit per unit insulin in hybrid closed-loop therapy
4:30 PM - 4:45 PMBiography
Dr Harshal Deshmukh is an endocrinologist and clinician-scientist based in regional Queensland, Australia. His research focuses on diabetes technology, insulin efficiency, and improving outcomes in underserved populations. He has published extensively and leads innovative clinical and implementation research to advance equitable, evidence-based diabetes and metabolic care.
Mr Neil Owens
Clinical Nurse Specialist
Health New Zealand Canterbury
Real-World impact of a national funding driven transition between automated insulin delivery system in paediatric Type 1 Diabetes
4:45 PM - 5:00 PMBiography
Clinical Nurse Specialist in Paediatric Diabetes at Christchurch Hospital for 20 years
Dr Aniket Nadkarni
Intensive Care Specialist
Adelaide University
Lack of concordance between subcutaneous continuous glucose monitoring and venous blood glucose during hypoglycaemia in type 1 diabetes
5:00 PM - 5:15 PMBiography
Dr Aniket Nadkarni is an intensive care specialist at the Austin Hospital, Melbourne, and is a PhD candidate at Adelaide University, with a thesis titled "Mitigating the short and long term complications of stress-induced hyperglycaemia". His research interests including glycaemic control in the critically ill, neurocritical care, and iatrogenic anaemia.
Dr Neisha D'Silva
Endocrinologist
Mater Hospital
Clinic-based eating disorder prevention in young women with Type 1 Diabetes: Effects of the Australian diabetes body project, randomized control trial
5:15 PM - 5:30 PMBiography
Dr Neisha D’Silva is a Senior Staff Endocrinologist at Mater Hospital Brisbane. She was lead author of the National Guidelines for the Assessment and Management of Disordered Eating/Eating Disorders (ED) in Type 1 Diabetes, endorsed by ADS, ANZSPED and ACBRD. Her clinical and research work focuses on diabetes-specific ED prevention.
Assoc Prof Glenn Ward
Deputy Director Of Endocrinology And Diabetes
St Vincent's Hospital
Changes in autoantibody levels from baseline after pancreatic islet allotransplantation in type 1 diabetes are not associated with changes in islet function or insulin therapy
5:30 PM - 5:45 PMBiography
A/Prof Glenn Ward is Deputy Director of Endocrinology, Head of Diabetes, and Clinical Consultant in Biochemistry at St Vincent’s Hospital Melbourne, and an Endocrinologist in the Australian Islet Transplant Program. Past roles include Medical Director of Pathology, President of the Australian Diabetes Society, and Board Member of Diabetes Australia National
Mr Aditya Nachanekar
Phd Candidate
Western Sydney University
Investigating the role of extracellular vesicles for type 1 diabetes therapy
5:45 PM - 6:00 PMBiography
Aditya Nachanekar is a final-year PhD student affiliated with the Western Sydney University, diabetes and islet biology group. His work focuses on investigating the role of extracellular vesicles obtained from human islet-derived progenitor cells in T1D therapy.
